JD Health International Inc. (JD Health) submitted its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming no change in outstanding share capital during the month while highlighting an ongoing share-buyback program.

Authorised and Issued Capital • Authorised share capital remained at 100 billion ordinary shares with a par value of USD 0.0000005 each, equivalent to total authorised capital of USD 50,000. • Issued shares stood at 3.21 billion, unchanged from the prior month. The company held no treasury shares as at 31 May 2026.

Public Float Compliance • JD Health affirmed compliance with the Hong Kong Stock Exchange’s minimum 25 % public-float requirement.

Share Repurchases • The company repurchased 15.95 million ordinary shares in May 2026 for cancellation. These shares had not yet been cancelled as of month-end, leaving the reported issued-share figure unaffected.

Equity Incentive Schemes • Pre-IPO ESOP: 9.43 million options remained outstanding; no grants, exercises, lapses or cancellations occurred in May. • Post-IPO Share Option Scheme: no options were outstanding, but 312.71 million shares remain available for future grants. • Post-IPO Share Award Scheme: up to 15.37 million shares could be issued under existing awards. • No shares were issued and no funds were raised from option exercises during the month.

Overall, JD Health’s capital structure stayed stable in May 2026, with the only notable activity being the ongoing share repurchase program yet to be reflected in the issued-share total.